XML 55 R43.htm IDEA: XBRL DOCUMENT v3.19.1
Related Parties Transactions (Details Textual) - USD ($)
1 Months Ended 12 Months Ended
Oct. 02, 2018
May 06, 2016
Nov. 29, 2018
Jun. 27, 2018
Jan. 18, 2018
Sep. 30, 2017
Jul. 24, 2017
Jan. 26, 2017
Dec. 31, 2018
Dec. 31, 2017
Aug. 25, 2018
May 09, 2018
Sep. 25, 2017
Related Parties Transactions (Textual)                          
Amount received from BriVision                 $ 4,462,775 $ 4,229,320      
Outstanding loan                 692,980 950,000      
Accrued interest                 281 17,460      
Interest expenses                 155,930 103,460      
Common stock new issues                 80,000 5,850,000      
Additional paid-in capital                 13,914,556 13,805,936      
Rent expenses                 0 52,205      
Related party transactions, description           Pursuant to the Investment and Equity Transfer Agreement, Everfront agreed to purchase 2,000,000 common shares of the Company owned by AsianGene at $1.60 per share in a total amount of $3,200,000, of which $160,000 is due before September 15, 2017 and the remaining amount of $3,040,000 is due before December 15, 2017. AsianGene also agreed to loan the proceeds to the Company for working capital purpose.              
Unsecured convertible promissory note [Member]                          
Related Parties Transactions (Textual)                          
Accrued interest                 27,467        
Aggregate principal amount       $ 250,000             $ 250,000 $ 300,000  
Chairman [Member]                          
Related Parties Transactions (Textual)                          
Aggregate working capital                 $ 100 $ 100      
Interest rate percentage                 0.00% 0.00%      
Collaborative Arrangement [Member]                          
Related Parties Transactions (Textual)                          
Amount received from BriVision                 $ 100,000,000        
Common stock new issues   $ 900,000         $ 3,000,000            
Due to BioFirst                         $ 3,000,000
Yuangene Corporation [Member]                          
Related Parties Transactions (Textual)                          
Amount received from BriVision                 92,690 $ 3,000      
Outstanding loan                 50,000 0      
Accrued interest                 5,721 0      
Interest expenses                 5,721 0      
Aggregate working capital         $ 50,000       $ 42,690 $ 3,000      
Interest rate percentage                 0.00% 0.00%      
Additional paid-in capital           $ 70,000              
Related party transactions, description         Under the terms of the loan agreement, the loan bears interest at 1% per month (or equivalent to 12% per annum) and the Company is required to pay interest monthly to the lender. The maturity date of this loan is January 19, 2019.                
Loan Agreement [Member]                          
Related Parties Transactions (Textual)                          
Total commitment               $ 950,000          
Loan maturity date               Feb. 01, 2018          
Loan agreement, description               The loan agreement, the loan bears interest at 1% per month (or equivalent to 12% per annum) and the Company is required to pay interest monthly to the lender.          
Asiangene Corporation [Member]                          
Related Parties Transactions (Textual)                          
Amount received from BriVision                 $ 160,000 $ 160,000      
Outstanding loan                 160,000 160,000      
Accrued interest                 12,866 0      
Interest expenses                 18,411 0      
BioLite [Member]                          
Related Parties Transactions (Textual)                          
Interest expenses                 306,821        
Aggregate working capital                 $ 58,684 $ 1,092,220      
Interest rate percentage                 0.00% 0.00%      
Additional paid-in capital                 $ 10,862,995        
BioFirst Corporation [Member]                          
Related Parties Transactions (Textual)                          
Amount received from BriVision                 4,151,301 $ 3,957,000      
Interest expenses                 104,331 103,460      
Aggregate working capital                 $ 458,321 $ 7,000      
Interest rate percentage                 0.00% 0.00%      
Keypoint Technology Ltd [Member] | Unsecured convertible promissory note [Member]                          
Related Parties Transactions (Textual)                          
Amount received from BriVision       $ 250,000                  
Interest expenses                 $ 10,222 $ 0      
Interest rate percentage       8.00%                  
Yoshinobu Odaira [Member] | Unsecured convertible promissory note [Member]                          
Related Parties Transactions (Textual)                          
Amount received from BriVision     $ 250,000                    
Interest expenses                 1,778 0      
Interest rate percentage     8.00%                    
Kimho Consultants Co., Ltd [Member]                          
Related Parties Transactions (Textual)                          
Stock based compensation expenses                 0 90,000      
Euro-Asia Agreement [Member]                          
Related Parties Transactions (Textual)                          
Stock based compensation expenses                 0 60,000      
LionGene Corporation [Member]                          
Related Parties Transactions (Textual)                          
One-time consulting service                   70,000      
BioKey [Member]                          
Related Parties Transactions (Textual)                          
Interest expenses                        
Additional paid-in capital                 82,265        
Monthly base rent $ 800                        
Rent expenses                 $ 2,400 $ 0